Amanote Research

Amanote Research

    RegisterSign In

Clinical Development of Anti-Rankl Therapy

Arthritis Research and Therapy - United Kingdom
doi 10.1186/ar2171
Full Text
Open PDF
Abstract

Available in full text

Categories
RheumatologyAllergyImmunology
Date

January 1, 2007

Authors
Edward M SchwarzChristopher T Ritchlin
Publisher

Springer Science and Business Media LLC


Related search

Clinical Prognosis and Basics of Anti-Neoplastic Therapy

Medycyna Weterynaryjna
Veterinary
2018English

RANKL Inhibition as Therapy for Joint Damage

Japanese Journal of Clinical Immunology
2007English

The RANKL-OPG System in Clinical Periodontology

Journal of Clinical Periodontology
Periodontics
2011English

Development of Therapeutic Anti-Jagged1 Antibodies for Cancer Therapy

Molecular Cancer Therapeutics
Cancer ResearchOncology
2019English

Development of HIV Vectors for Anti-Hiv Gene Therapy.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1996English

Anti-Cytokine Strategies Beyond Anti-Tumour Necrosis Factor-Α Therapy: Pathophysiology and Clinical Implications

Digestive Diseases
MedicineGastroenterology
2017English

Value Anti-Hepatitis C Virus Therapy by Its Clinical Efficacy

Hepatology
MedicineHepatology
2015English

Cronkhite-Canada Syndrome: Sustained Clinical Response With Anti-TNF Therapy

Case Reports in Medicine
Medicine
2018English

Serum Levels of OPG, RANKL and RANKL/OPG Ratios in Newly-Diagnosed Patients With Multiple Myeloma. Clinical Correlations

Haematologica
Hematology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy